Literature DB >> 24793150

[Polish respiratory society guidelines for chronic obstructive pulmonary disease].

Paweł Sliwiński1, Dorota Górecka, Ewa Jassem, Władysław Pierzchała.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24793150     DOI： 10.5603/PiAP.2014.0030

Source DB:  PubMed          Journal:  Pneumonol Alergol Pol        ISSN： 0867-7077


× No keyword cloud information.
  10 in total

1.  Prevalence, symptom burden and under-diagnosis of chronic obstructive pulmonary disease in Polish lung cancer screening population: a cohort observational study.

Authors:  Aleksandra Undrunas; Piotr Kasprzyk; Aleksandra Rajca; Krzysztof Kuziemski; Witold Rzyman; Tomasz Zdrojewski
Journal:  BMJ Open       Date:  2022-04-11       Impact factor: 2.692

Review 2.  Physical activity, sedentary behaviour and sleep in COPD guidelines: A systematic review.

Authors:  Hayley Lewthwaite; Tanja W Effing; Timothy Olds; Marie T Williams
Journal:  Chron Respir Dis       Date:  2017-02-24       Impact factor: 2.444

3.  Distribution and characteristics of COPD phenotypes - results from the Polish sub-cohort of the POPE study.

Authors:  Aleksander Kania; Rafał Krenke; Krzysztof Kuziemski; Małgorzata Czajkowska-Malinowska; Natalia Celejewska-Wójcik; Barbara Kuźnar-Kamińska; Małgorzata Farnik; Juliusz Bokiej; Marta Miszczuk; Iwona Damps-Konstańska; Marcin Grabicki; Marzena Trzaska-Sobczak; Krzysztof Sładek; Halina Batura-Gabryel; Adam Barczyk
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-05-17

4.  Standard expected years of life lost (SEYLL) due to chronic obstructive pulmonary disease (COPD) in Poland from 1999 to 2014.

Authors:  Elzbieta Dziankowska-Zaborszczyk; Marek Bryla; Beata Ciabiada-Bryla; Irena Maniecka-Bryla
Journal:  PLoS One       Date:  2019-03-12       Impact factor: 3.240

5.  Factors affecting the choice of therapeutic regimens in asthma and chronic obstructive pulmonary disease patients and patient adherence to the therapies prescribed.

Authors:  Paweł Nastałek; Adam Kurek; Agnieszka Almgren-Rachtan; Agnieszka Mastalerz-Migas; Zbigniew Doniec
Journal:  Postepy Dermatol Alergol       Date:  2018-04-03       Impact factor: 1.837

6.  Virtual Reality Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial.

Authors:  Sebastian Rutkowski; Anna Rutkowska; Paweł Kiper; Dariusz Jastrzebski; Henryk Racheniuk; Andrea Turolla; Jan Szczegielniak; Richard Casaburi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-01-13

7.  Active screening for COPD among hospitalized smokers - a feasibility study.

Authors:  Katarzyna Mycroft; Piotr Korczynski; Piotr Jankowski; Mikolaj Kutka; Olga Zelazna; Marcin Zagaja; Kornelia Wozniczko; Urszula Szafranska; Lukasz Koltowski; Grzegorz Opolski; Rafal Krenke; Katarzyna Gorska
Journal:  Ther Adv Chronic Dis       Date:  2020-12-14       Impact factor: 5.091

Review 8.  A review of national guidelines for management of COPD in Europe.

Authors:  Marc Miravitlles; Claus Vogelmeier; Nicolas Roche; David Halpin; João Cardoso; Alexander G Chuchalin; Hannu Kankaanranta; Thomas Sandström; Paweł Śliwiński; Jaromir Zatloukal; Francesco Blasi
Journal:  Eur Respir J       Date:  2016-01-21       Impact factor: 16.671

9.  Tobacco industry interference with tobacco control policies in Poland: legal aspects and industry practices.

Authors:  Łukasz Balwicki; Michał Stokłosa; Małgorzata Balwicka-Szczyrba; Wioleta Tomczak
Journal:  Tob Control       Date:  2015-09-28       Impact factor: 7.552

Review 10.  Chronic obstructive pulmonary disease guidelines in Europe: a look into the future.

Authors:  Marc Miravitlles; Nicolas Roche; João Cardoso; David Halpin; Zaurbek Aisanov; Hannu Kankaanranta; Vladimir Kobližek; Paweł Śliwiński; Leif Bjermer; Michael Tamm; Francesco Blasi; Claus F Vogelmeier
Journal:  Respir Res       Date:  2018-01-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.